DexCom (DXCM) Tops Q1 EPS by 2c; offers guidance
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $92.34 +2.35%
Financial Fact:
Product cost of sales: 47.5M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Product cost of sales: 47.5M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q1 EPS of $0.17, $0.02 better than the analyst estimate of $0.15. Revenue for the quarter came in at $741.5 million versus the consensus estimate of $720.67 million.
GUIDANCE:
DexCom sees FY2023 revenue of $3.4-3.515 million, versus the consensus of $3.47 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
- Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
